Advancing Care: Managing Small Late-Recurrence Hepatocellular Carcinoma with Image-guided Therapy

HomeRadiologyVol. 314, No. 2 PreviousNext Reviews and CommentaryEditorialAdvancing Care: Managing Small Late-Recurrence Hepatocellular Carcinoma with Image-guided TherapyMaxime Ronot Maxime Ronot Author AffiliationsFrom the Université Paris Cité, CRI UMR 1149, Paris, France; and Department of Radiology, Hôpital Beaujon, APHP.Nord, 100 Bd Général Leclerc, 92110 Clichy, France.Address correspondence to the author (email: [email protected]).Maxime Ronot Published Online:Feb 4 2025https://doi.org/10.1148/radiol.243768See also the article by Zhang and Chen et al in this issue.MoreSectionsFull textPDF ToolsAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookXLinked In References1. Zhang YJ, Chen MS, Chen Y, Lau WY, Peng Z. Long-term Outcomes of Transcatheter Arterial Chemoembolization Combined With Radiofrequency Ablation as an Initial Treatment for Early-Stage Hepatocellular Carcinoma. JAMA Netw Open 2021;4(9):e2126992. Medline Google Scholar2. Dan Y, Meng W, Li W, Chen Z, Lyu Y, Yu T. Transarterial Chemoembolization Combined With Radiofrequency Ablation Versus Hepatectomy for Hepatocellular Carcinoma: A Meta-Analysis. Front Surg 2022;9(9):948355. Medline Google Scholar3. Gui CH, Baey S, D'cruz RT, Shelat VG. Trans-arterial chemoembolization + radiofrequency ablation versus surgical resection in hepatocellular carcinoma - A meta-analysis. Eur J Surg Oncol 2020;46(5):763–771. Medline Google Scholar4. Zhang YJ, Chen J, Zhou Z, et al. Transarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular Carcinoma. Radiology 2025;314(2):e241096. Google Scholar5. Bholee AK, Peng K, Zhou Z, et al. Radiofrequency ablation combined with transarterial chemoembolization versus hepatectomy for patients with hepatocellular carcinoma within Milan criteria: a retrospective case-control study. Clin Transl Oncol 2017;19(7):844–852. Medline Google Scholar6. Pan T, Mu LW, Wu C, et al. Comparison of Combined Transcatheter Arterial Chemoembolization and CT-guided Radiofrequency Ablation with Surgical Resection in Patients with Hepatocellular Carcinoma within the Up-to-seven Criteria: A Multicenter Case-matched Study. J Cancer 2017;8(17):3506–3513. Medline Google Scholar7. Liu H, Wang ZG, Fu SY, et al. Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria. Br J Surg 2016;103(4):348–356. Medline Google Scholar8. Mohkam K, Dumont PN, Manichon AF, et al. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm. J Hepatol 2018;68(6):1172–1180. Medline Google Scholar9. de Baere T, Ronot M, Chung JW, et al. Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE). Cardiovasc Intervent Radiol 2022;45(10):1430–1440. Medline Google ScholarArticle HistoryReceived: Dec 10 2024Revision requested: Dec 16 2024Revision received: Dec 17 2024Accepted: Dec 17 2024Published online: Feb 04 2025 FiguresReferencesRelatedDetailsAccompanying This ArticleTransarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular CarcinomaFeb 4 2025Radiology Vol. 314, No. 2 Metrics Altmetric Score PDF download